Study Visits

Outcome measures in the CorEvitas AD Registry.

In addition to demographics, clinical features, medication history and changes, and comorbidities, key outcome measures collected include:

Clinician Reported Outcomes
  • Body Surface Area (BSA) Involvement
  • Eczema Area and Severity Index (EASI)
  • SCORing Atopic Dermatitis (SCORAD)
  • Validated Investigator Global Assessment scale for Atopic Dermatitis (vIGA-AD)
  • Nail changes due to atopic dermatitis (graduated Visual Analogue Scale)
Patient Reported Outcomes
  • Patient global assessments of disease control and severity
  • Dermatology Life Quality Index (DLQI)
  • Patient-Oriented Eczema Measure (POEM)
  • Atopic Dermatitis Control Tool (ADCT)
  • Peak pruritus Numerical Rating Scale
  • Sleeplessness and average pruritus (SCORAD)
  • Skin Pain Numerical Rating Scale
  • Fatigue Numerical Rating Scale
  • Itch triggers (PROMIS)
  • Work Productivity and Activity Impairment (WPAI)
Active safety assessments using structured data fields are collected with supporting documents to meet regulatory requirements and post marketing commitments of manufacturers.
Saturday September 7, 2019

Our Publications